These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 7812837)

  • 1. [Does selectivity in radical adenomectomy in invasive hypophyseal adenomas increase the risk of recurrence?].
    Malácek M; Steno J
    Bratisl Lek Listy; 1994 Aug; 95(8):349-53. PubMed ID: 7812837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term significance of microscopic dural invasion in 354 patients with pituitary adenomas treated with transsphenoidal surgery.
    Meij BP; Lopes MB; Ellegala DB; Alden TD; Laws ER
    J Neurosurg; 2002 Feb; 96(2):195-208. PubMed ID: 11838791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Radical and selective removal of hyperfunctional hypophyseal adenomas using a transsphenoidal approach].
    Steno J; Jezová D; Belan V; Tomecková E; Vigas M
    Cesk Neurol Neurochir; 1991 Mar; 54(2):107-15. PubMed ID: 1646081
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Value of endoscopy for maximizing tumor removal in endonasal transsphenoidal pituitary adenoma surgery.
    McLaughlin N; Eisenberg AA; Cohan P; Chaloner CB; Kelly DF
    J Neurosurg; 2013 Mar; 118(3):613-20. PubMed ID: 23240699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intraoperative high-field MRI for transsphenoidal reoperations of nonfunctioning pituitary adenoma.
    Berkmann S; Schlaffer S; Nimsky C; Fahlbusch R; Buchfelder M
    J Neurosurg; 2014 Nov; 121(5):1166-75. PubMed ID: 25127413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biochemical remission and recurrence rate of secreting pituitary adenomas after transsphenoidal adenomectomy: long-term endocrinologic follow-up results.
    Santoro A; Minniti G; Ruggeri A; Esposito V; Jaffrain-Rea ML; Delfini R
    Surg Neurol; 2007 Nov; 68(5):513-8; discussion 518. PubMed ID: 17961741
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endoscopic transsphenoidal treatment in recurrent and residual pituitary adenomas--first experience.
    Rudnik A; Zawadzki T; Gałuszka-Ignasiak B; Bazowski P; Duda I; Wojtacha M; Rudnik AI; Krawczyk I
    Minim Invasive Neurosurg; 2006 Feb; 49(1):10-4. PubMed ID: 16547875
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence.
    Losa M; Mortini P; Barzaghi R; Ribotto P; Terreni MR; Marzoli SB; Pieralli S; Giovanelli M
    J Neurosurg; 2008 Mar; 108(3):525-32. PubMed ID: 18312100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term recurrence and mortality after surgery and adjuvant radiotherapy for nonfunctional pituitary adenomas.
    Chang EF; Zada G; Kim S; Lamborn KR; Quinones-Hinojosa A; Tyrrell JB; Wilson CB; Kunwar S
    J Neurosurg; 2008 Apr; 108(4):736-45. PubMed ID: 18377253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pituitary function after selective adenomectomy for Cushing's disease.
    Post FA; Soule SG; De Villiers JC; Levitt NS
    Br J Neurosurg; 1995; 9(1):41-6. PubMed ID: 7786425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term surgical outcome in 16 patients with thyrotropin pituitary adenoma.
    Sanno N; Teramoto A; Osamura RY
    J Neurosurg; 2000 Aug; 93(2):194-200. PubMed ID: 10930003
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeat transsphenoidal surgery for Cushing's disease.
    Friedman RB; Oldfield EH; Nieman LK; Chrousos GP; Doppman JL; Cutler GB; Loriaux DL
    J Neurosurg; 1989 Oct; 71(4):520-7. PubMed ID: 2552045
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic endonasal surgery for giant pituitary adenomas: advantages and limitations.
    Koutourousiou M; Gardner PA; Fernandez-Miranda JC; Paluzzi A; Wang EW; Snyderman CH
    J Neurosurg; 2013 Mar; 118(3):621-31. PubMed ID: 23289816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypophyseal adenoma in elderly persons. Experience with surgical treatment of 102 patients].
    Patsko IaV; Vozniak AM; Guk AN; Paziuk VA
    Zh Vopr Neirokhir Im N N Burdenko; 2001; (4):14-8. PubMed ID: 11878211
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Stereotactic radiosurgery of pituitary adenomas.
    Liščák R; Ježková J; Marek J
    Neurosurg Clin N Am; 2013 Oct; 24(4):509-19. PubMed ID: 24093569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment and recurrences in 135 pituitary adenomas.
    Vlahovitch B; Reynaud C; Rhiati J; Mansour H; Hammoud F
    Acta Neurochir Suppl (Wien); 1988; 42():120-3. PubMed ID: 3189001
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GH replacement in patients with non-functioning pituitary adenoma (NFA) treated solely by surgery is not associated with increased risk of tumour recurrence.
    Arnold JR; Arnold DF; Marland A; Karavitaki N; Wass JA
    Clin Endocrinol (Oxf); 2009 Mar; 70(3):435-8. PubMed ID: 19236640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy for nonfunctional pituitary adenoma: analysis of long-term tumor control.
    Breen P; Flickinger JC; Kondziolka D; Martinez AJ
    J Neurosurg; 1998 Dec; 89(6):933-8. PubMed ID: 9833818
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active and silent thyroid-stimulating hormone-expressing pituitary adenomas: presenting symptoms, treatment, outcomes, and recurrence.
    Kirkman MA; Jaunmuktane Z; Brandner S; Khan AA; Powell M; Baldeweg SE
    World Neurosurg; 2014 Dec; 82(6):1224-31. PubMed ID: 24657816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Typical and atypical pituitary adenomas: a single-center analysis of outcome and prognosis.
    Chiloiro S; Doglietto F; Trapasso B; Iacovazzo D; Giampietro A; Di Nardo F; de Waure C; Lauriola L; Mangiola A; Anile C; Maira G; De Marinis L; Bianchi A
    Neuroendocrinology; 2015; 101(2):143-50. PubMed ID: 25633744
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.